» Articles » PMID: 20186491

Endothelial Dysfunction in Diabetes Mellitus: Molecular Mechanisms and Clinical Implications

Overview
Publisher Springer
Specialty Endocrinology
Date 2010 Feb 27
PMID 20186491
Citations 237
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular disease is a major complication of diabetes mellitus, and improved strategies for prevention and treatment are needed. Endothelial dysfunction contributes to the pathogenesis and clinical expression of atherosclerosis in diabetes mellitus. This article reviews the evidence linking endothelial dysfunction to human diabetes mellitus and experimental studies that investigated the responsible mechanisms. We then discuss the implications of these studies for current management and for new approaches for the prevention and treatment of cardiovascular disease in patients with diabetes mellitus.

Citing Articles

Microvascular Dysfunction Following Cardioplegic Arrest and Cardiopulmonary Bypass: Impacts of Diabetes and Hypertension.

Kanuparthy M, Manthana R, Kaushik H, Xiang K, Hamze J, Marimekala D Biomedicines. 2025; 13(2).

PMID: 40002822 PMC: 11853148. DOI: 10.3390/biomedicines13020409.


The Pathophysiology and Vascular Complications of Diabetes in Chronic Kidney Disease: A Comprehensive Review.

Hauwanga W, Abdalhamed T, Ezike L, Chukwulebe I, Ko Oo A, Wilfred A Cureus. 2025; 16(12):e76498.

PMID: 39872596 PMC: 11770394. DOI: 10.7759/cureus.76498.


Metformin-loaded nanoparticles reduce hyperglycemia-associated oxidative stress and induce eNOS phosphorylation in vascular endothelial cells.

Mohamed H, Mohamed N, Macasa S, Basha H, Adan A, Crovella S Sci Rep. 2024; 14(1):30870.

PMID: 39730492 PMC: 11681025. DOI: 10.1038/s41598-024-81427-6.


Integrative analysis of gene expression, protein abundance, and metabolomic profiling elucidates complex relationships in chronic hyperglycemia-induced changes in human aortic smooth muscle cells.

Bohara S, Bagheri A, Ertugral E, Radzikh I, Sandlers Y, Jiang P J Biol Eng. 2024; 18(1):61.

PMID: 39473010 PMC: 11523773. DOI: 10.1186/s13036-024-00457-w.


Dengue fever in hyperglycemic patients: an emerging public health concern demanding eyes on the effective management strategies.

Shawon S, Hamid M, Ahmed H, Khan S, Dewan S Health Sci Rep. 2024; 7(10):e70144.

PMID: 39421212 PMC: 11483528. DOI: 10.1002/hsr2.70144.


References
1.
Caballero A, Saouaf R, Lim S, Hamdy O, Abou-Elenin K, OConnor C . The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. Metabolism. 2003; 52(2):173-80. DOI: 10.1053/meta.2003.50023. View

2.
Milne J, Lambert P, Schenk S, Carney D, Smith J, Gagne D . Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007; 450(7170):712-6. PMC: 2753457. DOI: 10.1038/nature06261. View

3.
Michel J, Feron O, Sacks D, Michel T . Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem. 1997; 272(25):15583-6. DOI: 10.1074/jbc.272.25.15583. View

4.
Davda R, Stepniakowski K, Lu G, Ullian M, Goodfriend T, Egan B . Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension. 1995; 26(5):764-70. DOI: 10.1161/01.hyp.26.5.764. View

5.
Henriksen E . Improvement of insulin sensitivity by antagonism of the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2007; 293(3):R974-80. DOI: 10.1152/ajpregu.00147.2007. View